Boswellia
Evidence-Informed Formulation and Product
Selection
Last reviewed: September 2026
Affiliate Disclosure: This page contains affiliate links. If you purchase through one of these links, Verus PhytoMed™ may earn a commission at no additional cost to you. Products are selected and categorized using predefined formulation, quality, accessibility, and value criteria. Affiliate relationships and commission rates do not determine product inclusion or tier placement.
Supplement Options
The products below were selected using the Verus PhytoMed™ evaluation methodology. Selection emphasizes the identity of the Boswellia extract, alignment with doses used in human research, label transparency, manufacturing standards, accessibility, and value.
Premium Tier
The currently available standalone AprèsFlex® products use the same evidence-aligned extract and 100 mg daily dose. Verus PhytoMed™ did not identify a product offering a sufficiently meaningful advantage in formulation evidence or documented quality verification to justify a Premium designation.
Mid-Tier
Life Extension Boswellia
Trial-matched AprèsFlex® from an established supplement manufacturer
Why we selected it:
Uses AprèsFlex®/Aflapin®, the proprietary Boswellia serrata gum-resin extract evaluated in multiple randomized human trials
Provides 100 mg per vegetarian capsule, matching the once-daily amount used in the principal formulation-specific studies
Standardized to 20% AKBA
Uses a straightforward, single-extract formulation
Manufactured by an established supplement company with transparent quality-control practices
Selected based on formulation-specific clinical alignment, manufacturing transparency, and practical accessibility
Value Tier
Vitacost ROOT² Boswellia Serrata Featuring AprèsFlex®
Lower-cost access to the same trial-matched AprèsFlex® extract
Why we selected it:
Uses the same AprèsFlex®/Aflapin® extract evaluated in randomized human trials
Provides 100 mg per capsule, matching the once-daily amount used in the principal formulation-specific studies
Standardized to 20% AKBA
Offers the same extract and evidence-aligned dose as the Mid-Tier selection, generally at a lower price
Available through iHerb and Vitacost, supporting practical accessibility
Selected as a lower-cost option without sacrificing formulation-specific clinical alignment
Learn More
Read the Boswellia Monograph and Research Overview
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Disclaimer: The information provided by Verus PhytoMed™ is for educational purposes only and is not intended as medical advice. This overview summarizes current research and does not provide individualized treatment recommendations. Always consult your physician before starting any new supplement.

